tiprankstipranks
Quantum Biopharma (TSE:QNTM)
:QNTM
Canadian Market

Quantum Biopharma (QNTM) Financial Statements

Compare
62 Followers

Quantum Biopharma Financial Overview

Quantum Biopharma's market cap is currently $23.22M. The company's EPS TTM is C$-20.248; its P/E ratio is ―; Quantum Biopharma is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is C$-1.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Aug 17
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -19.23M$ -27.48M$ -33.81M$ -30.69M$ -19.37K
EBITDA-$ -22.57M$ -29.09M$ -24.46M$ -19.37K
Net Income$ -17.90M$ -23.61M$ -35.29M$ -31.80M$ -19.37K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 17.47M$ 38.41M$ 62.96M$ 41.97M$ 17.69K
Total Debt$ 339.20K$ 516.42K$ 555.90K$ 510.61K$ 35.00K
Net Debt$ -3.17M$ -16.46M$ -34.86M$ -17.01M$ 17.31K
Total Liabilities$ 4.57M$ 7.87M$ 9.22M$ 6.02M$ 113.22K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -10.83M$ -29.10M$ -21.25M$ -19.13M$ -21.11K
Operating Cash Flow$ -10.83M$ -28.33M$ -20.75M$ -19.13M$ -21.11K
Investing Cash Flow
Financing Cash Flow
Currency in USD

Quantum Biopharma Earnings and Revenue History

Quantum Biopharma Debt to Assets

Quantum Biopharma Cash Flow

Quantum Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis